Finance

Beta
Lists
TDAC:NASDAQ
Translational Development Acquisitin Crp
$10.75
-0.09%
(-0.010) 1D
May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TDAC...
Open
$10.80
High
$10.80
Low
$10.75
Mkt. cap
235.51M
Avg. vol.
124.70K
Volume
225.65K
P/E ratio
37.91
52-wk high
$10.80
52-wk low
$10.20
EPS
$0.28
Shares outstanding
17.25M
Open
$10.80
High
$10.80
Low
$10.75
Mkt. cap
235.51M
Avg. vol.
124.70K
Volume
225.65K
P/E ratio
37.91
52-wk high
$10.80
52-wk low
$10.20
EPS
$0.28
Shares outstanding
17.25M
News stories
From sources across the web
About Translational Development Acquisitin Crp
CEO-
Employees-
Founded2022
Headquarters-
SectorCapital market
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
221.13K
213.66K
162.34K
281.16K
Operating expense
221.13K
213.66K
162.34K
281.16K
Total operating expenses
221.13K
213.66K
162.34K
281.16K
Operating income
-221.13K
-213.66K
-162.34K
-281.16K
Other non operating income
-
-
-
-
EBT including unusual items
1.62M
1.66M
1.60M
1.33M
EBT excluding unusual items
1.62M
1.66M
1.47M
1.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
1.62M
1.66M
1.60M
1.33M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.84M
1.87M
1.63M
1.61M
Interest expense
-
-
-
-
Net interest expenses
1.84M
1.87M
1.63M
1.61M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more